Claire Wang

Claire Wang serves as an Industry Fellow at the UQ Centre for Clinical Research, The University of Queensland. Her research is anchored in clinical virology and infectious disease diagnostics, with substantial contributions to understanding viral pathogenesis and molecular detection methodologies across diverse pathogens including SARS-CoV-2, parechoviruses, and Plasmodium falciparum.

Her primary research interests span virology and infectious disease epidemiology, with specialized focus on molecular diagnostics for respiratory viruses and malaria. Wang has pioneered methodologies for viral genome characterization during outbreaks and developed quantitative PCR assays for pathogen detection. Her work integrates clinical specimens with molecular techniques to address public health challenges, particularly in pediatric populations and pandemic response scenarios.

Analysis of her publication record (2013-2023) reveals evolving research trajectories: early work centered on parechovirus epidemiology and malaria transmission mechanisms, while recent publications (2020-2023) dominate in SARS-CoV-2 variant characterization and diagnostic test validation. This shift reflects pandemic-driven priorities while maintaining core expertise in viral diagnostics. Her studies consistently employ molecular techniques including qPCR, next-generation sequencing, and viral culture assays across diverse clinical cohorts.

The provided materials indicate extensive collaborative networks across The University of Queensland and clinical partners, though specific laboratory leadership or team structures aren't detailed. Her research demonstrates strong translational focus, with findings directly informing diagnostic protocols and public health surveillance systems during viral outbreaks.